CURRICULUM VITAE YU-JUNG JENNY WEI, MSc., PhD September 2017 PRESENT POSITION Assistant Professor Department of Pharmaceutical Outcomes and Policy University of Florida, College of Pharmacy 1225 Center Drive, Room 3321 Gainesville, FL 32610-0496 Jenny.wei@cop.ufl.edu/352-294-5340 EDUCATION 2006-2012 1998-2000 1994-1998 Ph.D. in Pharmaceutical Health Services Research University of Maryland School of Pharmacy, Maryland, USA M.Sc. in Health Policy and Management National Taiwan University School of Public Health, Taipei, Taiwan B.S. in Public Health China Medical University School of Public Health, Taichung, Taiwan PROFESSIONAL APPOINTMENTS 2017-2019 Junior Scholar in Claude D. Pepper Older Americans Independence Center, Institute on Aging, Department of Aging & Geriatric Research, College of Medicine, University of Florida, USA 2015-present Assistant Professor, Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, USA 2012-2014 Post-doctoral Fellow, Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland Baltimore, USA 2006-2012 Graduate Research Assistant, Peter Lamy Center on Drug Therapy and Aging, University of Maryland Baltimore, USA 2002-2005 Research Assistant, Center for Health Policy Management, National Taiwan University, Taiwan 2000-2002 Research Fellow, Division of Cancer Prevention and Control, Department of Health, Taiwan GRANTS AND PROJECTS 8/1/2017-5/30/2022 NIH/NIA K01 Mentored Research Scientist Development Award ($605,298. Role: PI) Pharmacological Management of Pain in Alzheimer s Disease and Related Dementia
4/1/2017-3/30/2019 National Institute of Health (NIH)/National Institute on Aging (NIA) Claude D. Pepper Older Americans Independence Center grant at University of Florida, Junior Scholar Award ($150,000; Role: PI) Quality of Pharmacological Pain Prescribing in Nursing Home Residents with Alzheimer s Disease and Related Dementia 7/1/2016-6/30/2017 University of Florida College of Pharmacy PROSPER Excellence Award ($40,000; Role: PI) Pharmacological Management of Pain in Alzheimer s Disease and Related Dementia 11/1/2016 6/30/2017 Florida Agency for Healthcare Administration Program via a subcontract with the University of South Florida ($164,969; Role: Co-PI) Medicaid Drug Therapy Management Program for Behavioral Health Use of antipsychotics in preschoolers 2/1/2016 6/30/2016 Florida Agency for Healthcare Administration Program via a subcontract with the University of South Florida ($50,000; Role: PI) Long-term outcomes in Florida Medicaid beneficiaries who received antipsychotics under the prior authorization program 9/1/2013 8/31/2015 NIH/NIA 1R21AG045573-01 (PI: Simoni-Wastila Linda, University of Maryland Baltimore; $275,000; Role: Consultant) COPD Treatment in Older Adults with Depression SUBMITTED/UNDER REVIEW Grants 2018-2020 NIH/NIA R21 (Role: CO-PI with Almut Winterstein) Trajectories and determinants of prescription opioid use in older adults TEACHING 2017 Fall Co-lead instructor, PHA 5223: Pharmacoepidemiology and Drug Safety, University of Florida College of Pharmacy 2016 Fall Lead instructor, PHA 6805: Applied Data Analysis, Interpretation and Reporting of Findings in Pharmacy, University of Florida College of Pharmacy 2016 Fall Lecturer, PHA 5878C: Patient Care 3, University of Florida College of Pharmacy 2015 Fall/2017 Spring Co-instructor, PHA 6266: Introduction to Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy 2012 Guest Lecturer, PHSR 701: Research Methods I, University of Maryland School of Pharmacy HONORS
2017-2019 Junior Scholar Award, the NIH/NIA Claude D. Pepper Older Americans Independence Center (OAIC) at University of Florida 2006-2012 Graduate Student Fellowship Award, University of Maryland 2008-2012 Rho Chi Honor Society Membership 2011 Best Research Award, Treatment for Homeless Program Technical Assistance Workshop, SAMHSA PROFESSIONAL SERVICES Referee for scholarly journals: Research in Social and Administrative Pharmacy; Value in Health; Journal of Neurology, Neurosurgery & Psychiatry; Journal of Parkinsonism and Related Disorders; Journals of Gerontology, Series A: Biological Sciences and Medical Sciences; Alzheimer s Research & Therapy Judge for the best posters presented in 2015 UF College of Pharmacy Research Showcase Reviewer for abstracts submitted for 34rd International Society for Pharmacoepidemiology PROFESSIONAL MEMBERSHIPS International Society for Pharmacoepidemiology International Society for Pharmacoeconomics and Outcomes Research Gerontological Society of America PUBLICATIONS 1. Wei YJ, Simoni-Wastila L, Albrecht JS, Huang TY, Patience M, Khokhar B, Harris I, Lehmann SW, Langenberg P, Netzer G. 2017. Influence of antidepressant treatment on COPD maintenance medication use and adherence in a comorbid Medicare population: A longitudinal cohort study. The International Journal of Geriatric Psychiatry. Aug 22. doi: 10.1002/gps.4772 2. Wei YJ, Liu X, Rao N, McPherson M, Jones MB, Bussing R, and Winterstein AG. 2017. Physical health outcomes in preschoolers with prior authorization for antipsychotics. The Journal of Child and Adolescent Psychopharmacology. Jul 14. doi: 10.1089/cap.2017.000 3. Albrecht JS, Khokhar B, Huang TY, Wei YJ, Harris I, Patience M, Hur P, Netzer G, Lehmann SW, Langenberg P, Simoni-Wastila L. 2017. Adherence and Healthcare Utilization among Older Adults with COPD and Depression. Respiratory Medicine. Aug;129:53-58. doi: 10.1016/j.rmed.2017.06.002 4. Wei YJ, Simoni-Wastila L, Lucas JA, and Brandt N. 2016. Fall and fracture risk in nursing home residents with moderate-to-severe behavioral symptoms of Alzheimer s disease and related dementias initiating antidepressants or antipsychotics. The Journal of Gerontology: Series A: Medical Sciences. May 1;72(5):695-702. doi: 10.1093/gerona/glw095
5. Albrecht JS, Park Y, Hur P, Huang TY, Harris I, Netzer G, Lehmann SW, Langenberg P, Khokhar B, Wei YJ, and Simoni-Wastila L. 2016. Adherence to Maintenance Medications among Older Adults with Chronic Obstructive Pulmonary Disease: The Role of Depression. Annals of the American Thoracic Society. Sep;13(9):1497-504 doi: 10.1513/AnnalsATS.201602-136OC 6. Simoni-Wastila L, Wei YJ*(co-first authors, *corresponding author), Lucas JA, Brandt N, Moyo P, Huang TY, Franey C, Zuckerman IH. 2016. Mortality Risk of Antipsychotic Dose and Duration in Nursing Home Residents with Chronic or Acute Indications. Journal of the American Geriatrics Society 64(5):973-80. doi: 10.1111/jgs.14111. 7. Huang TY, Wei YJ, Moyo P, Zuckerman IH, Lucas JA, Simoni-Wastila L. 2015. Treated behavioral symptoms and mortality among Medicare nursing home residents with Alzheimer s disease and related dementias. Journal of the American Geriatrics Society 63(9): 1757-65. doi: 10.1111/jgs.13606 8. Wei YJ, Palumbo FB, Simoni-Wastila L, Shulman L, Stuart B, Beardsley R, Brown C. 2015. Relationships between antiparkinson drug nonadherence, modifications, and healthcare utilization and expenditures. Parkinsonism and Related Disorders 21(1):36-41. doi: 10.1016/j.parkreldis.2014.10.021. 9. Wei YJ, Simoni-Wastila L, Zuckerman IH, Huang TY, Brandt N, Moyo P, Lucas JA. 2014. Quality of psychopharmacological medication on mortality among Medicare nursing home residents. Journal of the American Geriatrics Society 62(8):1490-504. [Response to Lapane and colleagues. Journal of the American Geriatrics Society 63(4):834. doi: 10.1111/jgs.13360.] 10. Wei YJ, Simoni-Wastila L, Zuckerman IH, Brandt N, Lucas JA. 2014. Algorithm for identifying nursing home days using Medicare claims data and minimum data set assessment data. Medical Care. Nov;54(11):e73-e77 doi: 10.1097/MLR.0000000000000109. 11. Wei YJ, Palumbo FB, Simoni-Wastila L, Shulman L, Stuart B, Beardsley R, Brown C. 2014. Antiparkinson drug adherence and its association with healthcare utilization and economic outcomes in a Medicare Part D population. Value in Health 17(2):196-204. 12. Wei YJ, Palumbo FB, Simoni-Wastila L, Shulman L, Stuart B, Beardsley R, Brown C. 2013. Antiparkinson drug use and adherence in Medicare Part D beneficiaries with Parkinson s disease: patterns and associated factors. Clinical Therapeutics 35 (10):1513 1525.e1 13. Simoni-Wastila L, Wei YJ (corresponding author), Luong M, Franey C, Huang TY, Rattinger G, Zuckerman IH, Brandt N, Lucas JA. 2014. Quality of psychopharmacological medication use in nursing home residents. Research in Social and Administrative Pharmacy 10(3):494-507. 14. Qian J, Simoni-Wastila L, Rattinger B, Zuckerman I, Lehmann S, Wei YJ, Stuart B. 2014. Association between depression and maintenance medication adherence among Medicare beneficiaries with COPD. International Journal of Geriatric Psychiatry 29(1):49-57. 15. Simoni-Wastila L, Wei YJ (corresponding author), Qian J, Zuckerman IH, Stuart B, Shaffer T, Dalal A, Bryant-Comstock L. 2012. Association of COPD maintenance medication adherence with all-cause hospitalization and spending in a Medicare population. American Journal of Geriatric Pharmacotherapy 10(3):201-10. 16. Simoni-Wastila L, Qian J, Wei YJ, Zuckerman IH, Stuart B, Shaffer T, Dalal A, Bryant- Comstock L. 2012. Should Medicare rely on high drug spending as a criterion for medication therapy management programs? Journal of Pharmaceutical Health Services
Research 3 (4): 213-219. 17. Wei YJ, Stuart B, Zuckerman IH. 2010. Use of antiparkinson medications among the elderly Medicare beneficiaries with Parkinson s disease. American Journal of Geriatric Pharmacotherapy 8(4):384-94. 18. Cheng SH, Wei YJ, Chang HJ. 2006. Quality competition among hospitals: The effects of perceived quality and perceived expensiveness. American Journal of Medical Quality 21(1):68-75. 19. Wei YJ, Chung KP, Cheng SH. 2005. The evolution of healthcare quality assessment: From accreditation to report card system. Taiwan Journal of Public Health 24(4): 275-283. UNDER REVIEWED/SUBMISSION 1. Wei YJ, Liu W, Zhu Y, Liu X, and Winterstein AG. 2017. Polypharmacy involving prescription psychotropic and opioid medications in adults with attention deficit disorder, 1999-2010. Psychiatric Services. (under review) 2. Chen C & Wei YJ. Association between chronic pain and body weight in older adults with and without frailty (under review) 3. Chen C, Xiao H, Wei YJ and Hartzema A. A real-world assessment of treatment Persistence and switching of biologics in the patients with inflammatory bowel disease (under review) SYMPOSIUMS 1. Zullo AR, Moga DC, Gnjidic D, Wei YJ, and Lapane K. Conducting Pharmacoepidemiologic Research in the Nursing Home Population. International Society for Pharmacoepidemiology. Montreal Canada, Aug 26, 2017 Aug 30, 2017. ABSTRACTS 1. Chen C and Wei YJ (senior author). Chronic Pain, Pain Sites, and Analgesic Use by Body Mass Index Among U.S. Adults from NHANES. International Society for Pharmacoepidemiology. Montreal Canada, Aug 26, 2017 Aug 30, 2017. 2. Muñoz M, Winterstein AG, Delcher C, Kortepeter C, We YJ, Xiao H, Pan GD. Impact of a New Consumer-Friendly Form on Adverse Experience Reporting to the United States Food And Drug Administration. International Society for Pharmacoepidemiology. Montreal Canada, Aug 26, 2017 Aug 30, 2017. 3. Zhu Y, Hampp C, Wei Y, Roussos-Ross D, Brumback B, Winterstein AG. Validation of Algorithms to Estimate Gestational Age in Medicaid Analytic extract Data. International Society for Pharmacoepidemiology. Montreal Canada, Aug 26, 2017 Aug 30, 2017.(Oral) 4. Wei YJ, Liu X, Rao N, McPherson M, Jones MB, Bussing R, and Winterstein AG. Physical health outcomes in preschoolers with prior authorization for antipsychotics. International Society for Pharmacoepidemiology. Montreal Canada, Aug 26, 2017 Aug 30, 2017. 5. Wei YJ, Simoni-Wastila L, Albrecht J, Huang TY, Moyo P, Khokhar B, Harris IH, Langenberg P, Netzer G, and Lehmann S. Poster. Treated comorbid depression and COPD maintenance
medication use and adherence. International Society for Pharmacoepidemiology. Dublin, Ireland. Aug 25, 2016 - Aug 28, 2016. 6. Wei YJ, Simoni-Wastila L, Lucas JA, and Brandt N. Podium. Fall and fracture risk in nursing home residents with Alzheimer's disease and related dementia initiating antidepressants or antipsychotics. The Gerontological Society of America's Annual Scientific Meeting. New Orleans, LA. Nov 16, 2016 - Nov 20, 2016. 7. Albrecht J, Simoni-Wastila L, Wei YJ, Huang TY, Moyo P, Khokhar B, Harris IH, Langenberg P, Netzer G, and Lehmann S. Poster. Adherence to maintenance medications among older adults with chronic obstructive pulmonary disease: the role of depression. AcademyHealth s Annual Research Meeting. Boston, MA. Jun 26, 2016 - Jun 28, 2016. 8. Simoni-Wastila L, Wei YJ, Albrecht J, Huang TY, Moyo P, Khokhar B, Harris IH, Langenberg P, Netzer G, and Lehmann S. Poster. Influence of antidepressant treatment on use of and adherence to COPD maintenance medications. AcademyHealth s Annual Research Meeting. Boston, MA. Jun 26, 2016 - Jun 28, 2016. 9. Hur P, Albrecht J, Simoni-Wastila L, Huang TY, Moyo P, Wei YJ, Harris IH, and Khokhar B.. Poster. Relationship between severity and acute inhaler use in chronic obstructive pulmonary disease. ISPOR 21st Annual International Meeting. Washington, DC. May 23, 2016 - May 25, 2016. 10. Wei YJ, Simoni-Wastila L, Albrecht J, Huang TY, Moyo P, Khokhar B, Harris IH, Langenberg P, Netzer G, Lehmann S. Treated comorbid depression and COPD maintenance medication use and adherence. International Society for Pharmacoepidemiology, Dublin, Ireland. 2016. 11. Wei YJ, Simoni-Wastila L, Lucas JA, Brandt N, Moyo P, Huang T, Zuckerman IH. Morality risk of antipsychotic dose and duration among nursing home residents with chronic or acute indications. AcademyHealth s Annual Research Meeting, San Diego, CA. 2014. 12. Simoni-Wastila L, Wei YJ, Lucas JA, Brandt N, Moyo P, Huang T, Zuckerman IH. Influence of antipsychotic dose and duration on mortality among nursing home residents with appropriate indications for use. The Gerontological Society of America's 67th Annual Scientific Meeting, Washington, DC. 2014. 13. Simoni-Wastila L, Brandt N, Wei YJ, Huang TY, Moyo P, Franey C, Zuckerman I. Antipsychotics and other psychopharmacological medication use in United States nursing homes: What are the concerns and actions taking place to optimize prescribing? Alzheimer's Association International Conference. 2014. Printed in Alzheimer's and Dementia 10(4)Supplement: 278-279. 14. Wei YJ, Simoni-Wastila L, Huang TY, Moyo P, Franey C, Zuckerman IH. Impact of psychopharmacological medication use and quality on mortality among Medicare nursing home residents. AcademyHealth s Annual Research Meeting, Baltimore, MD. 2013. 15. Huang T, Simoni-Wastila L, Wei YJ, Luong M, Franey C, Rattinger G, Zuckerman IH, Brandt N. Psychopharmacological medication use in nursing home residents with delirium. International Society for Pharmacoepidemiology, Montreal, Canada. 2013. 16. Huang TY, Wei YJ, Simoni-Wastila L, Moyo P, Franey C, Zuckerman IH. Influence of antipsychotic and antidepressant use on mortality among Medicare nursing home residents with alzheimer s disease and related dementias. AcademyHealth s Annual Research Meeting, Baltimore, MD. 2013.
17. Moyo P, Wei YJ, Huang TY, Yang J, Woods C, Simoni-Wastila L. Opioid-Related Emergency department visits and hospital admissions in Maryland. AcademyHealth s Annual Research Meeting, Baltimore, MD. 2013. 18. Wei YJ, Palumbo FB, Simoni-Wastila L, Shulman L, Stuart B, Beardsley R, Brown C. Antiparkinson drug adherence and impact on Medicare Part D enrollees with Parkinson s disease. The Gerontological Society of America's 65th Annual Scientific Meeting, San Diego, CA. 2012. 19. Simoni-Wastila L, Wei YJ, Luong M, Franey C, Huang T, Rattinger GB, Zuckerman IH, Brandt N. Quality of psychopharmacological medication use in nursing home residents. The Gerontological Society of America's 65th Annual Scientific Meeting, San Diego, CA. 2012. 20. Simoni-Wastila L, Wei YJ, Luong M, Franey C, Huang T, Rattinger G, Zuckerman IH, Brandt N. Antipsychotic and other psychopharmacological medication use in nursing home residents with delirium. The Gerontological Society of America's 65th Annual Scientific Meeting, San Diego, CA. 2012. 21. Simoni-Wastila L, Wei YJ, Franey C, Luong M, Rattinger G, Zuckerman IH, Huang TY, Brandt N. Psychopharmacological medication use in nursing home residents: prevalence, patterns and indications of use. AcademyHealth Annual Research Meeting, Orlando, FL. 2012. 22. Wei YJ, Simoni-Wastila L, Campbell M, Siegel L, Briddell K, Keita J. Evaluation of a housing first model for chronically homeless people with substance use and/or psychiatric disorders in Baltimore, Maryland. Treatment for Homeless Program Technical Assistance Workshop, Baltimore, MD. 2011. 23. Simoni-Wastila L, Wei YJ, Qian J, Zuckerman IH, Stuart B, Shaffer T, Dalal A, Bryant- Comstock L. COPD maintenance medication adherence: influence on hospitalization and spending in a Medicare population. The 16 th International Society for Pharmacoeconomics and Outcome Research, Baltimore, MD. 2011. 24. Simoni-Wastila L, Qian J, Wei YJ, Stuart B, Zuckerman IH, Shaffer T, Dalal A, Bryant- Comstock L. Should Medicare rely on high drug spending as a criterion for medication therapy management services? AcademyHealth Annual Research Meeting, Seattle, WA. 2011. 25. Tomassello A, Daily V, and Wei YJ. HAART prescribing is significantly associated with housing status. Treatment for Homeless Program Technical Assistance Workshop, Arlington, VA. 2008. 26. Wei YJ and Cheng SH. Understanding quality competition among hospitals: The effects of perceived quality and perceived expensiveness. International Health Economics Association 5th World Congress, Barcelona, Spain. 2005.